Patents by Inventor Gerald Nakamura

Gerald Nakamura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190023770
    Abstract: The present invention provides anti-hemagglutinin antibodies, compositions comprising anti-hemagglutinin antibodies, and methods of using the same.
    Type: Application
    Filed: January 18, 2018
    Publication date: January 24, 2019
    Applicant: Genentech, Inc.
    Inventors: Min Xu, Mercedesz Balazs, Ning Chai, Nancy Y. Chiang, Henry Chiu, Zhaoyu Jin, Zhonghua Lin, Patrick Lupardus, Gerald Nakamura, Hyunjoo Park, Lee Swem
  • Publication number: 20060246004
    Abstract: The invention provides improved humanized CD20 binding antibodies for treatment of B cell malignancies and autoimmune diseases.
    Type: Application
    Filed: February 6, 2006
    Publication date: November 2, 2006
    Applicant: Genentech, Inc.
    Inventors: Camellia Adams, Henry Lowman, Gerald Nakamura
  • Publication number: 20060034835
    Abstract: The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.
    Type: Application
    Filed: June 7, 2005
    Publication date: February 16, 2006
    Applicant: Genentech, Inc.
    Inventors: Camellia Adams, Andrew Chan, Craig Crowley, Henry Lowman, Gerald Nakamura, Leonard Presta
  • Publication number: 20060024300
    Abstract: The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.
    Type: Application
    Filed: July 26, 2005
    Publication date: February 2, 2006
    Applicant: Genentech, Inc.
    Inventors: Camellia Adams, Andrew Chan, Craig Crowley, Henry Lowman, Gerald Nakamura, Leonard Presta